论文部分内容阅读
Lignan glycosides are ideal resources for antitumoral agents development.As semisynthetic lignan glycosides etoposide and teniposide have been widely used as antitumoral agents in clinical,[1] while another semisynthetic lignan glycoside,NK-611,is now in phse Ⅱ clinical trial.